Abstract 15 immunoglobulin heavy chain constant (CH) and variable region (VH) polymorphisms were selected to span the entire length of the heavy chain cluster. These polymorphisms were examined in 34 sib pairs concordant for multiple sclerosis (MS) and in 23 sporadic MS patients. Allele frequencies were calculated for the 2 MS patient groups and compared with those found in a control population from the same geographical location and of similar ethnic background. No significant association was found between MS and the 7 CH region polymorphisms examined. However, a significant correlation between the MS phenotype and a VH2 family polymorphism was observed in both MS patient populations (familial MS patients x2 = 8.16, P < 0.005; sporadic MS patients x2 = 8.90, P < 0.005). One allele of the VH2-5 gene segment was found to be overrepresented in both MS groups. VH2-5 has recently been physically mapped close to the CH region, between 180 and 360 kb away. These results indicate that a locus near or within the CH-proximal VH region is associated with increased susceptibility to MS. (J. Clin.
Introduction
Multiple sclerosis (MS)' is the most common chronic disease of the CNS affecting young adults, with a prevalence of -60 per 100,000 in the Northern United States (1) and of over 100 per 100,000 in Canada (2) . MS has a predilection for whites of Northern European descent. Patients commonly experience loss of vision, weakness, numbness, and impairment ofcoordination, among other symptoms (3) . These effects may be traced to impairment of the CNS white matter tracks which is itselfsecondary to the loss ofmyelin sheath with relative axonal preservation.
Familial aggregation of MS has been demonstrated (4, 5) . The higher concordance rates in monozygotic twins than in 1 . Abbreviations used in this paper: CH, immunoglobulin heavy chain constant region; IGH, immunoglobulin heavy chain; EAE, experimental allergic encephalomyelitis; HLA, human leukocyte antigen; MBP, myelin basic protein; MS, multiple sclerosis; VH, immunoglobulin heavy chain variable region.
dizygotic twins provides strong evidence for a genetically controlled susceptibility to MS (6, 7) . Despite this information, specific genes which predispose to MS have not been identified. However, an immune process is generally considered to be involved in MS initiation and progression.
Abnormalities of the immune system have been observed in the peripheral blood and CNS of MS patients although there is as yet no formal proofthat MS is mediated by either humoral or cellular mechanisms (for reviews see references [8] [9] [10] . Genetic susceptibility associated with the MHC locus of the human leukocyte antigen (HLA) system has been implicated. An increased frequency of the HLA-A3, B7, DR2 haplotype has been observed in European MS populations (reviewed in references 1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . However, many sib pairs concordant for MS do not share HLA haplotypes (14) .
Many spontaneous models of autoimmune disease invoke the interaction ofmultiple loci (15) . However, there is no spontaneous model of MS. Animal susceptibility to experimental allergic encephalomyelitis (EAE) , an autoimmune disease induced in animals by immunization with myelin, is also controlled by more than one locus (16) . Analysis of EAE animals indicates that T cells may have a role in the development of MS (reviewed in references 8, 10, 17) , although the failure to detect T cells reactive to myelin basic protein (MBP) in the peripheral blood of MS patients suggests that EAE could be distinct from MS (18) . Recent evidence suggests that a restricted set of the TCR Va and Ja gene segments are rearranged in the brains of MS patients (19) . Analysis of the distribution of haplotypes of the TCR a and ,B chain loci in MS patients suggests that T cells have a role in MS susceptibility (20) (21) (22) .
The immunoglobulin heavy chain (IGH) complex may also have a role in MS susceptibility and pathogenesis. Recent evidence suggests that increased levels of CNS autoantibodies are associated with MS disease activity and may be involved in the demyelination process (23, 24) . The systematic addition of antiwhite matter antibodies to EAE rodents was found not only to accelerate demyelination, but also to participate in the initiation of myelin breakdown (25) . While autoantibodies to CNS components may be secondary to the initiation of MS, the production of these autoantibodies could be important in the pathogenesis of MS and in potential antibody-dependent, cellmediated, demyelination. If this is the case, the genes of the IGH complex warrant study in MS patients.
To determine ifthe IGH complex has a role in MS susceptibility, polymorphisms of both the constant (CH) and the variable (VH) regions should be studied. DNA restriction fragment length polymorphisms have now been characterized for most of the CH region genes: ,, 6, y1, y3, a l, /,ey, y2, y4, and a2 (26) (27) (28) (29) (30) (31) . The recent completion of physical maps of the CH region (32, 33) has allowed comparison of the distribution of alleles of CH polymorphic loci with physical distance. Linkage disequilibrium analysis (27) and linkage analysis (34) (48) . This map includes the positions of VH polymorphic loci, and allowed our selection of eight VH polymorphic loci distributed over 1,000 kb of the VH region for use in disease association studies.
Based on the autoimmune reaction apparent in MS, and the HLA and TCR associations, we looked for association between MS and the immunoglobulin CH and VH regions. The allelic distributions of 15 DNA polymorphisms mapping to a 1,500-kb region of the IGH locus were determined for MS patients and controls in two consecutive studies. In both MS groups a significant association was found with a VH2 family gene segment. This suggests that the immunoglobulin VH region contributes to the genetic control of susceptibility to MS.
Methods
MSpatient ascertainment. The characteristics ofthe MS patient population from which the MS patients analyzed in this report were drawn have been extensively documented (2, 49 Control population. Controls used in this study consisted of members of a1-antitrypsin deficiency kindreds and 8 controls from other normal families. In this control population, 23 individuals were heterozygous for the aI-antitrypsin deficiency allele (the "Z" allele) and 39 were unrelated spouses (not containing the Z allele). 10 additional haplotypes were determined from incomplete pedigrees. a,-antitrypsin deficiency is a common metabolic disorder not known to be associated with MS (50) .
These controls were suitable for comparison, as they are of similar ethnic background (Caucasians of Northern European descent) and from the same geographical region (Southwestern Ontario) as both of the MS patient groups studied here, an important feature because of ethnic differences in IGH markers. Allele frequencies for this control population for the CH region polymorphisms (26, 27) and the VH region polymorphisms (42, 47 , and Gibson, unpublished results) were previously determined and are shown in Table I . DNA was extracted from peripheral blood leukocytes.
Electrophoretic analysis. 3 ,g ofDNA were digested with 9-12 U of the restriction endonucleases Bgl II, Eco RI, Sac I, Bam HI, and Xba I (Boehringer-Mannheim, Laval, Quebec, and Pharmacia Inc., Baie d'Urfe, Quebec) in manufacturers' recommended buffers overnight at 370C. Bgl II-, Eco RI-, and Sac I-digested DNA was electrophoresed in 0.7% agarose gels containing 0.8 gg/ml ethidium bromide for 1,200-1,600 volt-hours; Xba I-digested DNA was electrophoresed in 0.6% agarose for 1,400-1,500 Volt-hours; and Bam HI-digested DNA was electrophoresed in 0.35% agarose for 1,400-1,600 volt-hours. After being photographed, gels were submerged in 0.25 N HC1 for 10 min (20 min for Bam HI-digested DNA), briefly rinsed with distilled H20, denatured, neutralized, and transferred to Hybond nylon membrane according to the manufacturer's protocol (Amersham Corp., Arlington Heights, IL). Membranes were baked at 80'C for 2 h and cross-linked with ultraviolet light (365 nm, intensity 7,000 qW/cm2 at the filter were pooled. An allele size of 0 indicates that an allelic counterpart to a polymorphic fragment could not be found. Enzyme, the restriction enzyme used to detect the polymorphism. Frequency, The allele frequencies of the polymorphisms in the control population studied here. N, Number of control chromosomes typed. Reference, The original description of the polymorphism.
surface) for I min. The membranes were prehybridized for I h and hybridized for 18-24 h at 650C with 0.5-1.0 x 106 cpm of random primed probe per milliliter of hybridization solution (Pharmacia Inc. random priming kit). Prehybridization and hybridization solutions were as described (51 (53) . DNA probe and restriction enzyme combinations used to detect polymorphisms, and the reported allele frequencies in the control population are shown in Table I . Statistical analysis. The allele frequencies ofthe IGH polymorphic loci in the MS patient groups were compared with those of the control population by x2 analysis. To avoid false positives due to the large number of comparisons computed, only x2 values with probabilities of less than 0.01 were considered to be significant. Dosage of the VH insertion/deletion polymorphisms was determined by comparison of fragment hybridization intensities with intensities of constant bands within the same lane. Relative risk (x) was calculated using Wooifs formula: x = pd(l -pc)/(l -pd)pc (54) , where pd and pc are the frequencies of the phenotype in patient and control individuals, respectively.
Results
Study 1. 15 polymorphic loci mapping to a 1,500-kb region of the IGH locus were characterized in 32 sib pairs and 2 sib trios concordant for familial MS. For each polymorphism, one sib was randomly selected from each pair or trio and the genotype of that individual was used for data analysis. The allele frequencies for the familial MS group were then compared with the control population from Southern Ontario. The results of this analysis for the eight VH polymorphisms are shown in Table II ; the results of the analysis of the seven CH polymorphisms are shown in Table III Fig. 1 . In Table IV , the frequencies ofthe classes of sib pairs ofthe VH2-5 polymorphism observed in the familial MS sibships were compared with those found in the controls. This test uses the entire familial MS sib pair data set, rather than only half of it, as was previously done in Tables II and III . Two sibs were randomly selected from each of the two trio MS sibships for this analysis. The frequencies of the classes of sib pairs of the VH2-5 polymorphism MS population were found to differ significantly from the frequencies ofthe control population due to the elevated frequency of the 3.4-kb allele of VH2-5 in the MS patient group (X2 = 15.32, P < 0.001).
The MS patients were also investigated for possible alterations of the nonpolymorphic VH6 locus. Fig. 2 shows the physical localization of VH6, the most CH-proximal VH gene segment. In Bgl II-digested DNA the VH6B9.3 probe hybridizes to a 6.6-kb fragment containing the single VH6 gene segment and to a 20-kb fragment that is 5' of the VH6 locus (48) We compared the allele frequencies ofthe VH2-5 polymorphism in controls, with and without the a1-antitrypsin Z deficiency allele, since most ofour controls were from families with a,-antitrypsin deficiency. No association was found between the VH2-5 polymorphism and the a1-antitrypsin Z allele in our control population (X2 = 0.35).
The calculated x2 values of the 15 IGH polymorphic loci studied in the 2 MS patient populations and the physical locations of these polymorphic loci within the IGH complex are shown in Fig. 2 to differ (56) . In both of these MS groups, we found a significant association with the VH polymorphic locus VH2-5. The general low levels of linkage disequilibrium between the VH polymorphic loci in the normal population (47, 55) precluded the identification of VH region haplotypes in the MS patients. Efforts are now underway to characterize the parents or offspring of MS patients to investigate potential differences in VH haplotype frequencies in MS patients. We have selected a control population particularly well matched ethnically and geographically to our MS patients, because of well established ethnic differences for immunoglobulin markers. While we selected controls mostly from families with the a,-antitrypsin deficiency allele (Z), more than half were unrelated spouses. There is no association between the a,-antitrypsin Z allele and MS (50) . Furthermore, in our study, we have shown no difference between the VH2-5 allele frequencies in a1-antitrypsin PI type MZ (deficiency heterozygotes) and a, -antitrypsin non-Z individuals. Our control group is therefore suitable for disease association studies involving MS and VH2-5.
Previous studies investigating the role ofthe immunoglobulin heavy chain gene cluster in MS susceptibility have used only CH region polymorphisms. The results of these studies have been inconsistent. Several studies reported an elevation of the IgG marker Gm"'7;21 haplotype in MS patients (57) (58) (59) . However, Bulman et al. (60) found no association and Haile et al. (61) found no linkage between Gm markers and MS. Gaiser et al. (28) reported an association between a DNA polymorphism of IgG3 and MS, but found no association between IgG1 and MS. Furthermore, the IgG3 association was with the opposite allele of IgG3 reported elevated in MS patients in the previous studies (57) (58) (59) .
The different results found in the studies of association of the CH region of the IGH complex to MS susceptibility could be due to several factors. Geographical stratification and local variation in ethnic composition has been suggested as a possible explanation, as well as the possibility that different environmental factors may involve different MS susceptibility loci. However, as different results in association studies between MS and the CH region have been reported for MS patients from the same geographical regions (28, 57, 61, 62) , other explanations including incompatible control groups, may be more probable.
Our study, using seven CH region polymorphisms and eight VH polymorphisms, found no association between the CH region and MS patients, consistent with the earlier report in the Canadian MS population of no association with the Gm allotypes (60) . The recent identification ofa hot spot for recombination between the CA and Cy3 genes (27, 34) suggests that association between MS and the VH region could not be identified using IgG polymorphisms alone. The studies reported here are the first to use VH polymorphic loci in association studies with MS. We found that both familial MS and sporadic MS patient groups had a significantly increased frequency of the insertion allele of the VH2 polymorphic gene segment VH2-5.
VH2-5 has been mapped to a region between 180 and 360 kb from the CH region (48) . The VH5 polymorphic locus, (Table II) . tNo differences between the familial MS (-) patients and the control population were observed involving the non-polymorphic VH6 locus.
VH5-2, also maps to this interval ( Fig. 2) and shows some evidence of association with MS in both familial and sporadic MS groups (Table II) (63, 64) and in rheumatic disease (65, 66) . Alternatively, VH2-5 could be indirectly involved in MS susceptibility, perhaps mapping near a VH gene segment with MS-associated autoimmune specificity. With this in mind, it is intriguing that a VH3 family gene segment (PopVH) has recently been cloned that has anti-myelin and anti-DNA activities in a patient with peripheral neuropathy (67) . PopVH is 96% homologous to the VH3 gene segment VH26 (52) . VH26 has been shown to encode the heavy chain variable region of antibodies with anti-DNA activity (63, 66) . The sequence differences between PopVH and VH26 may be the result of somatic mutation, genetic variation of the same VH gene segment, or could imply that PopVH is encoded by a different germline VH3 gene segment that is very similar to VH26. As the VH26 gene segment has been physically localized close to VH2-5 (48), the germline PopVH gene segment may map to the same region as VH2-5, if similar VH gene segments are physically clustered, or if PopVH is an allele of the VH26 gene segment. We speculate that the association we have observed between MS and VH2-5 could be the result ofan association between MS and an anti-myelin VH gene segment which maps close to VH2-5. VH6, VH26, and VH2-5 have been associated with an autoimmune response (63) (64) (65) (66) ; and this paper). All of these VH gene segments are physically located in Immunoglobulin Association with Susceptibility to Multiple Sclerosis 1271 1 the CH-proximal VH region (48) . Others (38, 64, (68) (69) (70) have suggested that the VH gene segments mapping to this region are preferentially used in murine and human fetal ontogeny. It has been suggested that the cells expressing Ig receptors encoded by 3' VH gene families could be selected by antigen and/ or T cells early in ontogeny and in autoimmune diseases, as the VH from these families are preferentially used by autoreactive clones (71) . It will be interesting to discover whether the CHproximal VH gene segments generally encode autoantibodies, and ifthis autoantibody bias is associated with fetal expression.
The current evidence suggests that multiple sclerosis occurs in genetically susceptible individuals who are exposed to as yet unidentified environmental triggers. The data from this report suggest that a locus involved in genetic susceptibility to MS, in addition to loci near the HLA and TCR complexes, might be found in or near the immunoglobulin CH proximal VH region. These susceptibility loci may act in concert with each other in an epistatic manner, and with other, as yet unidentified loci, to provide the genetic background necessary for the development of multiple sclerosis.
